Atlatl Advisers LLC Sells 165 Shares of CME Group Inc. $CME

Atlatl Advisers LLC cut its holdings in shares of CME Group Inc. (NASDAQ:CME) by 7.3% during the second quarter, Holdings Channel.com reports. The firm owned 2,088 shares of the financial services provider’s stock after selling 165 shares during the period. Atlatl Advisers LLC’s holdings in CME Group were worth $575,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Webster Bank N. A. boosted its stake in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares in the last quarter. Highline Wealth Partners LLC boosted its stake in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares in the last quarter. Wayfinding Financial LLC bought a new position in shares of CME Group during the first quarter valued at approximately $25,000. Cornerstone Planning Group LLC boosted its stake in shares of CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 55 shares in the last quarter. Finally, Trifecta Capital Advisors LLC boosted its stake in CME Group by 59.2% in the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 42 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Trading Up 0.2%

NASDAQ:CME opened at $269.54 on Friday. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79. The firm has a fifty day simple moving average of $266.47 and a 200-day simple moving average of $271.78. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $97.14 billion, a P/E ratio of 26.12, a PEG ratio of 6.19 and a beta of 0.41.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the firm posted $2.68 earnings per share. The business’s revenue for the quarter was down 3.0% compared to the same quarter last year. On average, equities research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s payout ratio is presently 48.45%.

Insider Activity at CME Group

In related news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the transaction, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director William R. Shepard bought 262 shares of CME Group stock in a transaction that occurred on Thursday, September 25th. The shares were acquired at an average cost of $265.19 per share, with a total value of $69,479.78. Following the acquisition, the director owned 258,459 shares of the company’s stock, valued at $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. The Goldman Sachs Group raised their target price on shares of CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a research note on Thursday. UBS Group lowered their target price on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a research note on Thursday. Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and raised their target price for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Barclays lowered their target price on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 8th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a research note on Friday. Eight research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $284.53.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.